Skip to content

Effect of Different Subcutaneous Injection Methods on Pain and Satisfaction

Evaluation of the Effects of Different Methods Used in Subcutaneous Heparin Injections on Pain and Satisfaction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06829407
Enrollment
112
Registered
2025-02-17
Start date
2024-08-20
Completion date
2024-09-23
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute, Injection Site

Keywords

pain, low molecular weight heparin, palm stimulator, extended injection time

Brief summary

This study; In patients treated with subcutaneous heparin A randomized controlled trial was planned to determine the effect of the injection time and the device called Palm Stimulator to reduce the pain felt during injection.

Interventions

OTHERinjection time

give an injection

give an injection

OTHERinjection time and palm stimulator

give an injection

Sponsors

Trakya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

this study is an experimental, parallel-group (intervention-control), randomized controlled design

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Above 18 years old * The one who is literate, * No physical, mental disabilities or communication difficulties, * Low Molecular Weight Heparin in the treatment plan, * No history of allergy, * Agreeing to participate in the research, * There is no scar tissue, incision or infection in the area to be injected, * Patients who will receive a 1-day injection and whose pain score is between 1-10 according to VAS will be admitted.

Exclusion criteria

* Who gave up participating in the research while continuing the research, * Using subcutaneous insulin therapy, * There is an amputation in the right/left arm area where the study will be performed, * There is scar tissue, incision or signs of infection in the area to be injected, * Patients who received injections for 1 day and whose pain score is 0 (zero) according to VAS will not be admitted.

Design outcomes

Primary

MeasureTime frameDescription
Scale Patient Identification Formduring injection procedurePatient Identification Form It was prepared by researchers by examining the literature on the subject. This form includes 5 questions that include some sociodemographic characteristics of the individual (age, gender, marital status, education status, employment status, etc.) and 8 questions that include characteristics related to health, illness and treatment (presence of chronic disease, body mass index, etc.).
Visual Scale for painduring injection procedureVisual comparison scale for pain The scale consists of a single item, the scale is formed by a 10 cm long line on the horizontal plane. The leftmost side of the line (starting point) is scored as 0 (zero) and the rightmost side (ending point) is scored as 10 (ten) points for the highest possible pain. In order for the patient to score the pain, he/she is asked to mark a point on the line during the injection process. After marking, the distance from the starting point to the marked place is measured and the score is formed. The scale has been proven to be reliable in terms of Turkish as a result of the study conducted by Yaray et al.
Visual Comparison Scale for Satisfactionduring injection procedureVisual Comparison Scale for Satisfaction In this scale, scores between 0 and 10 were used to determine satisfaction levels. A score of 0 represented the least satisfaction level, while a score of 10 represented the highest satisfaction level. The Visual Analog Scale was used so that patients could express both their pain and satisfaction levels.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026